CalciMedica (CALC) Cash from Investing Activities (2019 - 2026)

CalciMedica (CALC) has 8 years of Cash from Investing Activities data on file, last reported at $1.5 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 220.68% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.3 million (up 65.31% YoY) and the FY2025 annual result came in at $9.6 million, up 315.94% from the prior year.
• Cash from Investing Activities slipped to $1.5 million in Q1 2026, from $7.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $9.8 million in Q2 2023 to a low of -$13.1 million in Q1 2024.
• A 5-year average of $1.1 million and a median of $817000.0 in 2025 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 118850.0% — and 2024, when it plunged 375.85%.
• Tracing CALC's Cash from Investing Activities over 5 years: stood at -$4000.0 in 2022, then sank by 66825.0% to -$2.7 million in 2023, then tumbled by 93.01% to -$5.2 million in 2024, then soared by 238.34% to $7.1 million in 2025, then sank by 79.02% to $1.5 million in 2026.
• The last three Cash from Investing Activities figures came in at $1.5 million (Q1 2026), $7.1 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.